Tag: Covid-ID Lab
-
![XPhyto Therapeutics (XPHY.C) Signs Acquisition Agreement with 3a-Diagnostics, Enters Biosensor Market]()
XPhyto Therapeutics (XPHY.C) Signs Acquisition Agreement with 3a-Diagnostics, Enters Biosensor Market
XPhyto Therapeutics (XPHY.C) announced today that it has signed a definitive agreement for the acquisition of 3a-Diagnostics GmhB, Frickenhausen, Germany, XPhyto’s exclusive diagnostic development partner. “We have collaborated closely with the 3a-diagnostics team on several diagnostics products and have found them to be a highly innovative and focused partner. The successful development and recent launch…
-
![XPhyto (XPHY.C) partner will begin sale of rapid Covid-ID Lab tests in Germany next week]()
XPhyto (XPHY.C) partner will begin sale of rapid Covid-ID Lab tests in Germany next week
XPhyto Therapeutics (XPHY.C) announced their partner Max Pharma GmbH will begin to sell XPhyto’s rapid point-of-care Covid-19 PCR test system (Covid-ID Lab) in Germany next week. The Covid-ID Lab test provides quality testing for the Covid-19 virus, achieving a 95% confidence interval, and delivering results within 25 minutes. Covid-ID Lab is registered within the European…
